Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cella

Showing results (351-360 of 1,016) with videos related to

Pageof 102
Sort By:
Journal of Pain and Symptom Management|April 15, 2009
Switching breast cancer patients with progressive bone metastases to third-generation bisphosphonates: measuring impact using the Functional Assessment of Cancer Therapy-Bone PainReuben Broom, Hongyan Du, Mark Clemons, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group studyAlice B Kornblith, Helen Q Huang, Joan L Walker, et al.
Journal of Pain and Symptom Management|June 15, 2010
Age-associated differences in fatigue among patients with cancerZeeshan Butt, Arati V Rao, Jin-Shei Lai, et al.
World Journal of Gastrointestinal Oncology|February 28, 2020
Neuropathy experienced by colorectal cancer patients receiving oxaliplatin: A qualitative study to validate the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scaleKaren Kaiser, Madison Lyleroehr, Sara Shaunfield, et al.
Advances in Therapy|January 12, 2021
Patient and Healthcare Provider Perspectives of First-Generation Somatostatin Analogs in the Management of Neuroendocrine Tumors and Acromegaly: A Systematic Literature ReviewDavid Cella, Jennifer Evans, Marion Feuilly, et al.
Cancer|May 29, 2020
Validation of the Functional Assessment of Cancer Therapy-Leukemia instrument in patients with acute myeloid leukemia who are not candidates for intensive therapyJohn Devin Peipert, Susan E Yount, Fabio Efficace, et al.
JMIR Cancer|July 15, 2024
Do Measures of Real-World Physical Behavior Provide Insights Into the Well-Being and Physical Function of Cancer Survivors? Cross-Sectional AnalysisShelby L Bachman, Emma Gomes, Suvekshya Aryal, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2011
Examining web equivalence and risk factor sensitivity of the COPD population screenerJennifer L Beaumont, David Victorson, Jun Su, et al.
Melanoma Research|October 27, 2011
Health-related quality of life among patients with metastatic melanoma: results from an international phase 2 multicenter studyDonald W Robinson, Janice N Cormier, Ning Zhao, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 30, 2009
Evaluating minimal important differences for the FACT-Melanoma quality of life questionnaireRobert L Askew, Yan Xing, J Lynn Palmer, et al.
Pageof 102

Showing results (351-360 of 1,016) with videos related to

Sort By:
Pageof 102
Journal of Pain and Symptom Management|April 15, 2009
Switching breast cancer patients with progressive bone metastases to third-generation bisphosphonates: measuring impact using the Functional Assessment of Cancer Therapy-Bone PainReuben Broom, Hongyan Du, Mark Clemons, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group studyAlice B Kornblith, Helen Q Huang, Joan L Walker, et al.
Journal of Pain and Symptom Management|June 15, 2010
Age-associated differences in fatigue among patients with cancerZeeshan Butt, Arati V Rao, Jin-Shei Lai, et al.
World Journal of Gastrointestinal Oncology|February 28, 2020
Neuropathy experienced by colorectal cancer patients receiving oxaliplatin: A qualitative study to validate the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scaleKaren Kaiser, Madison Lyleroehr, Sara Shaunfield, et al.
Advances in Therapy|January 12, 2021
Patient and Healthcare Provider Perspectives of First-Generation Somatostatin Analogs in the Management of Neuroendocrine Tumors and Acromegaly: A Systematic Literature ReviewDavid Cella, Jennifer Evans, Marion Feuilly, et al.
Cancer|May 29, 2020
Validation of the Functional Assessment of Cancer Therapy-Leukemia instrument in patients with acute myeloid leukemia who are not candidates for intensive therapyJohn Devin Peipert, Susan E Yount, Fabio Efficace, et al.
JMIR Cancer|July 15, 2024
Do Measures of Real-World Physical Behavior Provide Insights Into the Well-Being and Physical Function of Cancer Survivors? Cross-Sectional AnalysisShelby L Bachman, Emma Gomes, Suvekshya Aryal, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2011
Examining web equivalence and risk factor sensitivity of the COPD population screenerJennifer L Beaumont, David Victorson, Jun Su, et al.
Melanoma Research|October 27, 2011
Health-related quality of life among patients with metastatic melanoma: results from an international phase 2 multicenter studyDonald W Robinson, Janice N Cormier, Ning Zhao, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 30, 2009
Evaluating minimal important differences for the FACT-Melanoma quality of life questionnaireRobert L Askew, Yan Xing, J Lynn Palmer, et al.
Pageof 102